ÂÜÀòÂÒÂ×

Marina Roy Luzarraga currently serves as an In vivo Scientist at Artios Pharma Ltd since November 2020, following a tenure as a Postdoctoral Researcher at Barts Cancer Institute from November 2015 to November 2020, where project management, data analysis, scientific writing, and manuscript preparation were key responsibilities. Previously, Marina conducted laboratory research on tumor angiogenesis and drug resistance during a PhD program, also engaging in significant research activities at the CNIO - Spanish National Cancer Research Centre from September 2012 to October 2015, and worked in various research assistant roles at multiple institutions, including The Netherlands Cancer Institute and the Bellvitge Biomedical Research Institute. Marina holds a PhD in Biomedical Sciences from Queen Mary University of London, a Master's in Molecular Biomedicine from Universidad Autónoma de Madrid, and a Bachelor's degree in Biology from Universitat de Barcelona.